Michael Woerner and a team of attorneys, are investigating cases involving patients who took Invokana, Invokamet, or Invokamet XR and suffered an amputation as a result.
Lynn Sarko has been appointed to serve on the Plaintiffs’ Steering Committee in the litigation to hold Fiat Chrysler Automobiles accountable to consumers for developing and marketing trucks with so-called “EcoDiesel” engines.
Lynn Sarko has been appointed to serve on the Plaintiffs’ Steering Committee in the litigation to hold Fiat Chrysler Automobiles accountable to consumers for developing and marketing trucks with so-called “EcoDiesel” engines.
The cases seek to make the care and treatment for Type 1 and Type 2 Diabetes Patients more affordable and increase pricing transparency in the pharmaceutical industry.
Details have come to light about a conspiracy among manufacturers of automobile door locking mechanisms that has had the effect of raising the price of that vital component and hence of any car that includes one of those latches.
Keller Rohrback is investigating the increased risk of leg and foot amputations when taking the SGLT2 inhibitors: Invokana, Invokamet, Invokamet XR for the treatment of type 2 diabetes.
Judge Charles M. Breyer granted final approval to the 3.0-Liter Class Action Settlement with Volkswagen, and also granted final approval to a $327.5 million settlement with Bosch
